SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,538,458 | -0.9% | 109,795 | +12.4% | 0.01% | 0.0% |
| Q2 2023 | $2,561,405 | -9.4% | 97,689 | -11.0% | 0.01% | -16.7% |
| Q1 2023 | $2,825,942 | +25.9% | 109,788 | +27.2% | 0.01% | +20.0% |
| Q4 2022 | $2,245,052 | -23.5% | 86,315 | -16.2% | 0.01% | -16.7% |
| Q3 2022 | $2,936,000 | +92.0% | 102,981 | +65.7% | 0.01% | +100.0% |
| Q2 2022 | $1,529,000 | -44.8% | 62,150 | +26.7% | 0.00% | -40.0% |
| Q1 2022 | $2,768,000 | +7.5% | 49,050 | +18.0% | 0.01% | +25.0% |
| Q4 2021 | $2,575,000 | +29.7% | 41,572 | +32.8% | 0.00% | +33.3% |
| Q3 2021 | $1,985,000 | -7.0% | 31,309 | +20.8% | 0.00% | -25.0% |
| Q2 2021 | $2,135,000 | +2746.7% | 25,920 | +1340.0% | 0.00% | – |
| Q2 2020 | $75,000 | – | 1,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |